CCL19 and systemic sclerosis: A recent study demonstrated that CCL19 was more strongly expressed in systemic sclerosis (SSc) skin and was correlated to vascular inflammation [19], providing further evidence for the role of CCL19 in perivascular inflammation and immune cell recruitment.